Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors

Peptides

Volumn 32, Issue 5, 2011, Pages 1060-1067

  Qi, Tao ^a   Ly, Kien ^a   Poyner, David R ^b   Christopoulos, George ^c   Sexton, Patrick M ^c   Hay, Debbie L ^a,d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ASTON UNIVERSITY   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN RECEPTOR; ALANINE; ARGININE; ASPARAGINE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP; GLUTAMINE; MUTANT PROTEIN; PHENYLALANINE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; SERINE; THREONINE; TRYPTOPHAN; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION;

ADRENOMEDULLIN; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PROTEIN BINDING; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79955442428     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.03.004     Document Type: Article

References (31)

1. R.J. Bailey, and D.L. Hay Pharmacology of the human CGRP1 receptor in Cos 7 cells Peptides 27 2006 1367 1375
2. R.J. Bailey, and D.L. Hay Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor Br J Pharmacol 151 2007 678 687 (Pubitemid 47016286)
3. S. Banerjee, J. Evanson, E. Harris, S.L. Lowe, R. Speth, and K.A. Thomasson Identification of specific calcitonin-like receptor residues important for calcitonin gene-related peptide high affinity binding BMC Pharmacol 6 2006 9
4. J. Barwell, P.S. Miller, D. Donnelly, and D.R. Poyner Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor Peptides 31 2010 170 176
5. K.M. Caron, and O. Smithies Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene Proc Natl Acad Sci U S A 98 2001 615 619 (Pubitemid 32105091)
6. M. Chauhan, K. Rajarathnam, and C. Yallampalli Role of the N-terminal domain of the calcitonin receptor-like receptor in ligand binding Biochemistry 44 2004 782 789
7. N.J. Fraser, A. Wise, J. Brown, L.M. McLatchie, M.J. Main, and S.M. Foord The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor Mol Pharmacol 55 1999 1054 1059 (Pubitemid 29252372)
8. K.L. Fritz-Six, W.P. Dunworth, M. Li, and K.M. Caron Adrenomedullin signaling is necessary for murine lymphatic vascular development J Clin Invest 118 2008 40 50
9. D.L. Hay, G. Christopoulos, A. Christopoulos, D.R. Poyner, and P.M. Sexton Pharmacological discrimination of calcitonin receptor - receptor activity modifying protein complexes Mol Pharmacol 67 2005 1655 1665 (Pubitemid 40594165)
10. D.L. Hay, G. Christopoulos, A. Christopoulos, and P.M. Sexton Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l- piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl] -2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors - the role of receptor activity modifying protein 1 Mol Pharmacol 70 2006 1984 1991 (Pubitemid 44771914)
11. S. Hilairet, S.M. Foord, F.H. Marshall, and M. Bouvier Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins J Biol Chem 276 2001 29575 29581
12. T.W. Ho, L.K. Mannix, X. Fan, C. Assaid, C. Furtek, and C.J. Jones Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine Neurology 70 2008 1304 1312 (Pubitemid 351550355)
13. S. Iimuro, T. Shindo, N. Moriyama, T. Amaki, P. Niu, and N. Takeda Angiogenic effects of adrenomedullin in ischemia and tumor growth Circ Res 95 2004 415 423 (Pubitemid 39100460)
14. L.M. Ittner, D. Koller, R. Muff, J.A. Fischer, and W. Born The N-terminal extracellular domain 23-60 of the calcitonin receptor-like receptor in chimeras with the parathyroid hormone receptor mediates association with receptor activity-modifying protein 1 Biochemistry 44 2005 5749 5754 (Pubitemid 40525111)
15. K. Kuwasako, K. Kitamura, K. Ito, T. Uemura, Y. Yanagita, and J. Kato The seven amino acids of human RAMP2 (86-92) and RAMP3 (59-65) are critical for agonist binding to human adrenomedullin receptors J Biol Chem 276 2001 49459 49465
16. K. Kuwasako, K. Kitamura, Y. Nagoshi, Y.-N. Cao, and T. Eto Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity J Biol Chem 278 2003 22623 22630 (Pubitemid 36830320)
17. L.H. Lassen, P.A. Haderslev, V.B. Jacobsen, V.K. Iversen, B. Sperling, and J. Olesen CGRP may play a causative role in migraine Cephalalgia 22 2002 54 61 (Pubitemid 34626025)
18. M. Li, D. Yee, T.R. Magnuson, O. Smithies, and K.M. Caron Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice J Clin Invest 116 2006 2653 2662 (Pubitemid 44511629)
19. L.M. McLatchie, N.J. Fraser, M.J. Main, A. Wise, J. Brown, and N. Thompson RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor Nature 93 1998 333 339 (Pubitemid 28269699)
20. E.L. Moore, J.J. Gingell, S.A. Kane, D.L. Hay, and C.A. Salvatore Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding Biochem Biophys Res Commun 394 2010 141 145
21. J. Olesen, H.C. Diener, I.W. Husstedt, P.J. Goadsby, D. Hall, and U. Meier Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine N Engl J Med 350 2004 1104 1110 (Pubitemid 38298990)
22. T. Qi, G. Christopoulos, R.J. Bailey, A. Christopoulos, P.M. Sexton, and D.L. Hay Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function Mol Pharmacol 74 2008 1059 1071
23. T. Qi, and D.L. Hay Structure-function relationships of the N-terminus of receptor activity-modifying proteins Br J Pharmacol 159 2010 1059 1068
24. T. Qi, J. Simms, R.J. Bailey, M. Wheatley, D.L. Rathbone, and D.L. Hay Structure-function analysis of RAMP1-RAMP3 chimeras Biochemistry 49 2009 522 531
25. S.D. Robinson, J.F. Aitken, R.J. Bailey, D.R. Poyner, and D.L. Hay Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3 J Pharmacol Exp Ther 331 2009 513 521
26. J. Roh, C.L. Chang, A. Bhalla, C. Klein, and S.Y.T. Hsu Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes J Biol Chem 279 2004 7264 7274 (Pubitemid 38248876)
27. J. Simms, D.L. Hay, M. Wheatley, and D.R. Poyner Characterization of the structure of RAMP1 by mutagenesis and molecular modeling Biophys J 91 2006 662 669
28. J. Simms, D.L. Hay, R.J. Bailey, G. Konycheva, G. Bailey, and M. Wheatley Structure function analysis of RAMP1 by alanine mutagenesis Biochemistry 48 2009 198 205
29. Y. Takei, S. Hyodo, T. Katafuchi, and N. Minamino Novel fish-derived adrenomedullin in mammals: structure and possible function Peptides 25 2004 1643 1656 (Pubitemid 39346206)
30. E. ter Haar, C.M. Koth, N. Abdul-Manan, L. Swenson, J.T. Coll, and J.A. Lippke Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism Structure 18 2010 1083 1093
31. E.T. Zumpe, N. Tilakaratne, N.J. Fraser, G. Christopoulos, S.M. Foord, and P.M. Sexton Multiple ramp domains are required for generation of amylin receptor phenotype from the calcitonin receptor gene product Biochem Biophys Res Commun 267 2000 368 372 (Pubitemid 30072558)